Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) fell 1.1% during mid-day trading on Monday . The stock traded as low as €27.64 ($32.14) and last traded at €27.67 ($32.17). 3,613,197 shares changed hands during mid-day trading, The stock had previously closed at €27.97 ($32.52).
Bayer Aktiengesellschaft Price Performance
The firm has a market cap of $27.82 billion, a PE ratio of -31.61, a P/E/G ratio of 36.39 and a beta of 0.97. The business’s fifty day moving average is €25.85 and its 200-day moving average is €23.24.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Further Reading
- Five stocks we like better than Bayer Aktiengesellschaft
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Domino’s Delivers Another Discounted Entry for Income Investors
- What is a Death Cross in Stocks?
- TSLA Earnings Week: Can Tesla Break Through $350?
- How to Use the MarketBeat Excel Dividend Calculator
- Goldman, Morgan Stanley, & BofA: Diverging Paths After Earnings
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
